6-K - Prenetics Global Limited | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Prenetics Global Limited appointed Dr. Darshan Shah, a renowned longevity expert and CEO of Next Health, as an independent director to its Board of Directors effective February 16, 2026. Dr. Shah will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, strengthening the Board's clinical and commercial expertise for IM8 growth.

Key Takeaways

1Dr. Darshan Shah appointed independent director effective February 16, 2026

2Dr. Shah joins Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee

3Dr. Shah is Founder and CEO of Next Health, expanding to over 30 locations by end of 2026

4Dr. Shah performed over 20,000 surgeries and trained at Mayo Clinic

5IM8 surpassed $100 million in annualized recurring revenue within 11 months and sold in over 30 countries

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Executive & Director Changes

Dr. Darshan Shah

Independent Director; Member of Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee

Appointed

Effective: 2026-02-16

Exhibits (2)

6-K

99.1

EX-99.1